Influence of Rapeseed Proteins on the Postprandial Metabolic Response

May 18, 2020 updated by: Ulf Schlegelmilch, Martin-Luther-Universität Halle-Wittenberg

Influence of Rapeseed Proteins on the Postprandial Metabolic Response.

The aim of the study is to investigate the effect of rapeseed proteins on the postprandial metabolic response. Therefore, study participants will receive a meal rich in fat and carbohydrates with and without rapeseed protein or with soy protein that serves as control.

Study Overview

Status

Completed

Conditions

Detailed Description

The current study is a monocentric, controlled intervention study that will be conducted as cross-over design. Three interventions are planned and participants will be invited to consume a test meal with added rapeseed protein isolate, a test meal with added soy protein isolate and a test meal without additional protein. The evening before, the subjects will receive a standardized dinner. After a 12-hour fasting overnight, a cannula will be placed. Blood samples will be taken before and after eating the test meal rich in carbohydrate and fat. The test meal consists of pasta with oily tomato sauce with either 25 g of rapeseed protein, 25 g of soy protein or no additional protein. A total of 11 blood samples will be collected over a period of 6 hours. In the meantime, the blood pressure and pulse will be measured repeatedly and information on satiety will be recorded. The interventions will be interrupted by a period of, at least, 2 weeks.

Study Type

Interventional

Enrollment (Actual)

20

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Saxony Anhalt
      • Halle, Saxony Anhalt, Germany, 06120
        • Martin-Luther-University Institute of Agriculture and Nutritional Science

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

Yes

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • healthy men and women
  • age between 18 and 65 years
  • informed consent
  • body mass index between 18,5 up to 29,9 kg/m2
  • anamnesis without diagnostic findings

Exclusion Criteria:

  • acute or chronic diseases ((hypertension, coronary diseases, renal diseases, diabetes, alcohol abuse etc.)
  • intake of drugs (exemption: oral contraceptive)
  • pregnancy or lactation
  • food intolerance or allergies to mustard, soy, tomato, wheat
  • participation on another trial
  • blood donation - while last 2 month before the start of the study
  • extensive physical activity (competitive sports, hard physical work)
  • diet procedure
  • smoking

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Crossover Assignment
  • Masking: Double

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: rapeseed protein
Three interventions are planned, in which the subjects will eat a test meal with added rape protein isolate (arm 1), a test meal with added soy protein isolate (arm 2) and a test meal without additional protein (arm 3) in random order on 3 days. The subjects are randomly assigned to one of the 3 treatment arms, ultimately resulting in 6 sequences (cross-over)
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day
Active Comparator: soy protein
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day
Placebo Comparator: no protein
25g rapeseed protein in comparison to 25g soy protein or no protein - dosage of 25 g per day

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
time course of glucose level
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial blood glucose level
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Cholesterol
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of Cholesterol
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
triglycerides
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of triglycerides
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
short chain fatty acids
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of short chain fatty acids
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
indole-3-propionate
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of indole-3-propionate
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
amino acids
Time Frame: 0,15,30,45,60,90,120 and 180 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of amino acids
0,15,30,45,60,90,120 and 180 min after ingestion of testmeal rich in carbohydrates and fat
hormones (insulin, ghrelin, FGF23)
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of hormones (insulin, ghrelin, FGF23)
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
time course of urea level,
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of urea
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
minerals and blood hsCRP
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
Impact of rapeseed protein on the postprandial levels of minerals and blood hsCRP
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
systolic and diastolic blood pressures
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
time course: measurement of blood pressure in mm Hg
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
feeling of satiety by means of a questionnaire
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
heart rate
Time Frame: 0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat
time course: measurement of heart rate in beats per minute
0,15,30,45,60,90,120,180,240,300 and 360 min after ingestion of testmeal rich in carbohydrates and fat

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gabriele Stangl, Prof.Dr., MLU, Institut für Agrar-und Ernährungswissenschaften

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 16, 2018

Primary Completion (Actual)

April 6, 2019

Study Completion (Actual)

December 15, 2019

Study Registration Dates

First Submitted

June 26, 2018

First Submitted That Met QC Criteria

August 6, 2018

First Posted (Actual)

August 8, 2018

Study Record Updates

Last Update Posted (Actual)

May 19, 2020

Last Update Submitted That Met QC Criteria

May 18, 2020

Last Verified

May 1, 2020

More Information

Terms related to this study

Other Study ID Numbers

  • UFOP 062018

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Health, Subjective

Clinical Trials on rapeseed or soy protein or no protein

3
Subscribe